Christine M N Smith

Title: Inventor Profile: Christine M N Smith

Introduction

Christine M N Smith, based in San Diego, CA, is an accomplished inventor known for his contributions to the field of pharmaceuticals. His work focuses on innovative methods of treating conditions related to insulin regulation, showcasing a commitment to improving healthcare outcomes.

Latest Patents

Christine holds two patents that emphasize his expertise in liquid pharmaceutical formulations. His latest inventions include:

1. **Methods of using buffered formulations of exendin (9-39)** - This patent describes liquid pharmaceutical formulations containing exendin (9-39) or its pharmaceutically acceptable salts along with a tonicity modifier in a physiologically acceptable buffer, maintaining a pH range of about 5 to about 6. Additionally, the formulation may incorporate acetate or citrate buffers, aimed at treating or preventing hyperinsulinemic hypoglycemia in subjects.

2. **Buffered formulations of exendin (9-39)** - Similar to the previous patent, this invention outlines liquid pharmaceutical formulations that use exendin (9-39) or its salts in combination with tonicity modifiers in a physiologically acceptable buffer. This formulation also targets the treatment of hyperinsulinemic hypoglycemia, demonstrating its significant therapeutic potential.

Career Highlights

Throughout his career, Christine has contributed to key projects at notable institutions. He has worked with Eiger Biopharmaceuticals, Inc. and Leland Stanford Junior University, where his research has paved the way for innovative solutions in pharmaceutical science.

Collaborations

Christine has collaborated with several esteemed colleagues, including Xiaofeng Xiong and Debra Odink, enhancing the collective knowledge and impact within his research teams. These collaborations have been instrumental in advancing his work and in the development of his patented formulations.

Conclusion

Christine M N Smith stands out as a notable inventor whose work in pharmaceutical formulations continues to address critical health challenges. With his innovative patents and collaborative efforts, he contributes significantly to advancing medical treatments, particularly in insulin regulation and related disorders. His ongoing commitment to research and innovation makes him a key figure in the pharmaceutical landscape.